Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bill Ackman’s Pershing Square Not Selling CP Rail

Bill Ackman’s Pershing Square recently bought a 12.2% stake in Canadian Pacific Railway. The moved spurred speculation that the well-known activist hedge fund manager might seek a sale, reports Businessweek.

Bill Ackman isn’t Selling CP Rail

Bill Ackman isn’t planning on selling. “We don’t think the company should be sold,” Ackman said yesterday according to Businessweek. “This is not a case where we’re pushing to sell the company. We don’t think that’s a good way to optimize the outcome for shareholders.” Over the weekend, CP rail told employees in a memo that it is “open to the views of its shareholders.” It said, “We will speak with Pershing Square to hear their input into our plan, already targeted at realizing greater efficiency and improved service reliability.” Businessweek reports that Ed Greenburg, a spokesman for CP Rail, “has said the railroad isn’t commenting on Ackman’s investment.”


Pershing Square is an Activist Hedge Fund

Bill Ackman’s Pershing Square is an activist hedge fund. This means that it buys stakes in companies that are large enough to provide the fund a voice in its management and operations. Ackman then pushes for the changes that will bring the greatest shareholder value, generally either revamping operations, installing new management or provoking a sale or division of the company. For example, Ackman did this recently with JC Penney (JCP) when he advocated to install Ron Johnson, ex-Apple exec, as the company’s CEO.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!